TherapeuticsMD, Inc. Operating Cash Flow
TherapeuticsMD, Inc. (TXMD) reported Operating Cash Flow of -$8.70 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-05-15
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$8.70M.
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$18.92M.
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$27.06M.
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$17.87M.
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$142.69M.
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$159.47M.
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$165.72M.
- TherapeuticsMD, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$106.81M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | -$8.70M 10-Q · filed 2023-05-15 | |||||||
| 2022-09-30 | -$18.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$45.98M derived: sum of 2 quarters · filed 2022-11-14 | -$63.85M 10-Q · filed 2022-11-14 | -$103.41M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-06-30 | -$27.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$44.93M 10-Q · filed 2022-08-15 | -$84.49M derived: sum of 3 quarters · filed 2023-05-15 | -$122.71M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-03-31 | -$17.87M 10-Q · filed 2023-05-15 | -$29.53M 10-Q · filed 2022-05-16 | -$57.43M derived: sum of 2 quarters · filed 2023-05-15 | -$95.65M derived: sum of 3 quarters · filed 2023-05-15 | -$122.19M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$39.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$77.78M derived: sum of 2 quarters · filed 2022-11-14 | -$104.31M derived: sum of 3 quarters · filed 2022-11-14 | -$142.69M 10-K · filed 2022-03-23 | ||||
| 2021-09-30 | -$38.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$64.75M derived: sum of 2 quarters · filed 2022-11-14 | -$103.14M 10-Q · filed 2022-11-14 | -$133.49M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$26.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$64.91M 10-Q · filed 2022-08-15 | -$95.27M derived: sum of 3 quarters · filed 2022-08-15 | -$129.32M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$38.38M 10-Q · filed 2022-05-16 | -$68.74M derived: sum of 2 quarters · filed 2022-05-16 | -$102.79M derived: sum of 3 quarters · filed 2022-05-16 | -$158.74M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$30.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$64.41M derived: sum of 2 quarters · filed 2022-03-23 | -$120.36M derived: sum of 3 quarters · filed 2022-03-23 | -$159.47M 10-K · filed 2022-03-23 | -$159.47M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | -$34.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$90.00M derived: sum of 2 quarters · filed 2021-11-12 | -$129.11M 10-Q · filed 2021-11-12 | -$129.15M 10-Q · filed 2020-11-09 | -$179.93M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-06-30 | -$55.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$95.06M 10-Q · filed 2021-08-04 | -$95.10M 10-Q · filed 2020-08-07 | -$145.88M derived: sum of 3 quarters · filed 2022-03-23 | -$172.11M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-03-31 | -$39.11M 10-Q · filed 2021-05-06 | -$39.11M 10-Q · filed 2020-05-06 | -$89.93M derived: sum of 2 quarters · filed 2022-03-23 | -$116.15M derived: sum of 3 quarters · filed 2022-03-23 | -$166.67M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2019-12-31 | -$50.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$77.04M derived: sum of 2 quarters · filed 2022-03-23 | -$127.55M derived: sum of 3 quarters · filed 2022-03-23 | -$165.72M 10-K · filed 2022-03-23 | -$165.70M 10-K · filed 2020-02-24 | |||
| 2019-09-30 | -$26.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$76.74M derived: sum of 2 quarters · filed 2020-11-09 | -$114.90M 10-Q · filed 2020-11-09 | -$143.05M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | -$50.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$88.68M 10-Q · filed 2020-08-07 | -$116.82M derived: sum of 3 quarters · filed 2021-03-04 | -$150.89M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | -$38.16M 10-Q · filed 2020-05-06 | -$66.31M derived: sum of 2 quarters · filed 2021-03-04 | -$100.38M derived: sum of 3 quarters · filed 2021-03-04 | -$125.33M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | -$28.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$62.21M derived: sum of 2 quarters · filed 2021-03-04 | -$87.16M derived: sum of 3 quarters · filed 2021-03-04 | -$106.81M 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | -$34.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$59.02M derived: sum of 2 quarters · filed 2019-11-08 | -$78.67M 10-Q · filed 2019-11-08 | -$99.47M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | -$24.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$44.60M 10-Q · filed 2019-08-09 | -$65.40M derived: sum of 3 quarters · filed 2020-02-24 | -$82.09M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | -$19.65M 10-Q · filed 2019-05-08 | -$40.46M derived: sum of 2 quarters · filed 2020-02-24 | -$57.14M derived: sum of 3 quarters · filed 2020-02-24 | -$75.28M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | -$20.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$37.49M derived: sum of 2 quarters · filed 2020-02-24 | -$55.63M derived: sum of 3 quarters · filed 2020-02-24 | -$76.16M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | -$16.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$34.82M derived: sum of 2 quarters · filed 2018-11-08 | -$55.35M 10-Q · filed 2018-11-08 | -$70.97M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | -$18.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$38.67M 10-Q · filed 2018-07-30 | -$54.28M derived: sum of 3 quarters · filed 2019-02-27 | -$73.08M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | -$20.53M 10-Q · filed 2018-05-07 | -$36.14M derived: sum of 2 quarters · filed 2019-02-27 | -$54.94M derived: sum of 3 quarters · filed 2019-02-27 | -$70.26M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$15.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$34.42M derived: sum of 2 quarters · filed 2019-02-27 | -$49.74M derived: sum of 3 quarters · filed 2019-02-27 | -$69.14M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$18.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$34.12M derived: sum of 2 quarters · filed 2017-11-07 | -$53.52M 10-Q · filed 2017-11-07 | -$70.13M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | -$15.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$34.73M 10-Q · filed 2017-08-03 | -$51.33M derived: sum of 3 quarters · filed 2018-02-23 | -$69.77M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | -$19.40M 10-Q · filed 2017-05-03 | -$36.01M derived: sum of 2 quarters · filed 2018-02-23 | -$54.45M derived: sum of 3 quarters · filed 2018-02-23 | -$79.30M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | -$16.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$35.05M derived: sum of 2 quarters · filed 2018-02-23 | -$59.89M derived: sum of 3 quarters · filed 2018-02-23 | -$79.04M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | -$18.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$43.28M derived: sum of 2 quarters · filed 2016-11-04 | -$62.43M 10-Q · filed 2016-11-04 | -$77.72M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$24.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$44.00M 10-Q · filed 2016-08-05 | -$59.28M derived: sum of 3 quarters · filed 2017-02-28 | -$70.74M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$19.15M 10-Q · filed 2016-05-05 | -$34.43M derived: sum of 2 quarters · filed 2017-02-28 | -$45.89M derived: sum of 3 quarters · filed 2017-02-28 | -$55.96M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$15.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$26.74M derived: sum of 2 quarters · filed 2017-02-28 | -$36.82M derived: sum of 3 quarters · filed 2017-02-28 | -$45.52M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | -$11.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$21.53M derived: sum of 2 quarters · filed 2015-11-05 | -$30.24M 10-Q · filed 2015-11-05 | -$35.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | -$10.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$18.78M 10-Q · filed 2015-08-07 | -$23.55M derived: sum of 3 quarters · filed 2016-02-26 | -$28.86M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | -$8.71M 10-Q · filed 2015-05-07 | -$13.47M derived: sum of 2 quarters · filed 2016-02-26 | -$18.79M derived: sum of 3 quarters · filed 2016-02-26 | -$25.97M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | -$4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$10.08M derived: sum of 2 quarters · filed 2016-02-26 | -$17.26M derived: sum of 3 quarters · filed 2016-02-26 | -$20.77M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | -$5.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$12.49M derived: sum of 2 quarters · filed 2014-11-07 | -$16.00M 10-Q · filed 2014-11-07 | -$15.89M 10-Q · filed 2013-11-05 | -$20.01M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-06-30 | -$7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$10.68M 10-Q · filed 2014-08-07 | -$14.69M derived: sum of 3 quarters · filed 2015-03-12 | -$17.77M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | -$3.51M 10-Q · filed 2014-05-07 | -$7.52M derived: sum of 2 quarters · filed 2015-03-12 | -$10.60M derived: sum of 3 quarters · filed 2015-03-12 | -$13.79M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -$4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$7.09M derived: sum of 2 quarters · filed 2015-03-12 | -$10.29M derived: sum of 3 quarters · filed 2015-03-12 | -$12.74M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | -$3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$6.28M derived: sum of 2 quarters · filed 2013-11-05 | -$8.73M 10-Q · filed 2013-11-05 | -$8.40M 10-Q · filed 2012-11-13 | -$10.62M derived: sum of 4 quarters · filed 2014-03-05 | |||
| 2012-06-30 | -$3.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$5.65M 10-Q · filed 2013-08-07 | -$5.25M 10-Q · filed 2012-08-09 | -$7.53M derived: sum of 3 quarters · filed 2014-03-05 | -$9.05M derived: sum of 4 quarters · filed 2014-03-05 | |||
| 2012-03-31 | -$2.45M 10-Q · filed 2013-05-10 | -$4.34M derived: sum of 2 quarters · filed 2014-03-05 | -$5.86M derived: sum of 3 quarters · filed 2014-03-05 | -$6.66M derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2011-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | -$3.40M derived: sum of 2 quarters · filed 2014-03-05 | -$4.21M derived: sum of 3 quarters · filed 2014-03-05 | -$4.97M 10-K · filed 2014-03-05 | ||||
| 2011-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$2.32M derived: sum of 2 quarters · filed 2012-11-13 | -$3.08M 10-Q · filed 2012-11-13 | -$202.17K 10-Q · filed 2011-11-07 | ||||
| 2011-06-30 | -$801.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$1.56M 10-Q · filed 2012-08-09 | -$146.95K 10-Q · filed 2011-08-15 | |||||
| 2011-03-31 | -$760.74K 10-Q · filed 2012-05-11 | |||||||
| 2010-09-30 | $411.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $30.60K 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | -$380.93K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |